Clinical Trials and Scoliosis
Links shared publicly online about this topic.
- 493total visits
Clinical Trials and Scoliosis
View full resource at spineuniverse.com
Tags: Clinical Trial, Scoliosis
Most Recently Shared on February 20, 2011 at 8:01 am By:
Drug May Lower Gluten Toxicity in Patients with Celiac Disease - Celiac.com
celiac.com — “Biopharmaceutical development company, BioLineRx, has announced results from pre-clinical trials which show that their compound, BL-7010, an orally available treatment for celiac disease, reduces the ...” View full resource at celiac.com
Most Recently Shared on April 18, 2012 at 9:19 am By:
Drug May Lower Gluten Toxicity in Patients with Celiac Disease - http://t.co/2y1rcrPk http://t.co/r31MN96a #GF #Celiac
Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on April 17, 2012 at 5:32 pm By:
Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing http://t.co/bhrtpYpP cool hotel room and a cell phone #cure
Research roundup: Obesity treatment for low-income patients; Medicare vs. private plans
news-medical.net — “Low-income patients are underrepresented in clinical trials and are disproportionately prone to obesity and the related problems of high blood pressure and heart disease. Researchers conducted a 24-month trial of more than 300 low-income, obese patients from various Boston community health centers, randomizing participants "to usual care or a behavioral intervention that promoted weight loss and hypertension self-management using eHealth components. The intervention included tailored behavi” View full resource at news-medical.net
Most Recently Shared on April 16, 2012 at 10:10 am By:
Medicare News: Research roundup: Obesity treatment for low-income patients; Medicare vs. private plans: Low-inco... http://t.co/B4HhfRqn
New male birth control shot is 100% effective and lasts 10 years | Nerve.com
nerve.com — “New birth control 100% effective more men” View full resource at nerve.com
Most Recently Shared on April 12, 2012 at 7:15 pm By:
This is called RISUG or the VasalGel contraceptive and is early clinical trials in India. For accuracy, it is a... http://t.co/Gc02ytBe
AIDSmeds - Top Stories : HIV Vaccine Study Offers Up Possible Antibody Protection Clues
aidsmeds.com — “Scientists continued to unravel clues as to why a combination of two preventive HIV vaccines, ALVAC HIV and AIDSVAX B/E, may have worked for some but not others in a large scale clinical trial reported in 2009.” View full resource at aidsmeds.com
Most Recently Shared on April 11, 2012 at 4:47 pm By:
#HIV Vaccine Study Offers Up Possible Antibody Protection Clues http://t.co/sn2eWy1q @pozmagazine Join the Conversation
5 Food-Medicines That Could Quite Possibly Save Your Life
greenmedinfo.com — “Natural remedies may exist in your backyard, refrigerator or spice rack. Plenty of scientific research confirms ancient wisdom. Let food be your medicine. The science supports Turmeric, Apples, Garlic, Honey and sunlight for disease prevention and treatment.” View full resource at greenmedinfo.com
Most Recently Shared on April 11, 2012 at 1:39 pm By:
Targacept: Drug missed goal due to analysis error - BusinessWeek
businessweek.com — “Drug developer Targacept Inc. said Tuesday that further analysis showed an experimental asthma treatment failed one one of its goals in a clinical trial, contrary to what the company previously reported.” View full resource at businessweek.com
Most Recently Shared on April 11, 2012 at 5:11 am By:
Targacept: Drug missed goal due to analysis error - BusinessWeek: Targacept: Drug missed goal due to analy... http://t.co/vyiiMVfu #drug
T-Cell Lymphoma Clinic Trials - YouTube
youtube.com — “Our mission is to improve the cure rate of patients with PTCL and reduce treatment-related toxicity by developing novel targeted therapy using rationally des...” View full resource at youtube.com
Most Recently Shared on April 10, 2012 at 11:50 pm By:
T cell lymphoma Program at MDACC offers innovative clinical trials... http://t.co/Dgc99sKT
A Chance at Normal Life for Children with Rare Diseases | Clinical & Translational Science Institute
ctsi.ucsf.edu — “A Chance at Normal Life for Children with Rare Diseases | Clinical & Translational Science Institute” View full resource at ctsi.ucsf.edu
Most Recently Shared on April 10, 2012 at 9:47 pm By:
Children’s Hospital & Research Center Oakland's clinical trials are the best hope of survival for children with... http://t.co/IX4QFm06
Clinical Drug Trials Increasingly More Available for Individuals with Autism
emaxhealth.com — “The US Food and Drug Administration has approved two medicines for treating one symptom of autism spectrum disorders (irritability) but the agency has...” View full resource at emaxhealth.com
Most Recently Shared on April 10, 2012 at 1:35 pm By:
Clinical Drug Trials Increasingly More Available for Individuals with Autism: http://t.co/dhtOoUqJ
Canon, MEDIAN to demonstrate LMS clinical application portfolio at ITEM
news-medical.net — “MEDIAN Technologies, a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials and clinical routine, announced today it will demonstrate its Lesion Management Solutions -LMS- clinical application portfolio together with Canon at ITEM, April 13-15, 2012 in Yokohama, Japan.” View full resource at news-medical.net
Most Recently Shared on April 10, 2012 at 11:50 am By:
Lung Cancer News: Canon, MEDIAN to demonstrate LMS clinical application portfolio at ITEM: MEDIAN Technologies, ... http://t.co/CnPDGIyF
Dr. Mesa Discusses the COMFORT Ruxolitinib Trials
onclive.com — “Dr. Ruben Mesa, from Mayo Clinic, Arizona, Discusses the COMFORT Ruxolitinib Trials” View full resource at onclive.com
Most Recently Shared on April 9, 2012 at 9:05 pm By:
OncLive TV: Dr. Ruben Mesa Discusses the COMFORT Ruxolitinib Trials http://t.co/WxzutZEf
Alarms Field Assessment Survey
jointcommission.qualtrics.com — “Survey Software, Enterprise Survey software for enterprise feedback management and CRM solutions. Enables high-quality data collection, panel management and results analysis. Perfect for market research or CRM solution (Customer Relationship Management) integration. Free trial and consultation.” View full resource at jointcommission.qualtrics.com
Most Recently Shared on April 6, 2012 at 8:32 pm By:
Please participate in The Joint Commission’s Alarm Field Assessment Survey, which takes about 10 minutes to... http://t.co/Xwr09MxS
Nanoparticle-delivered RNA interference drug stops head and neck cancer growth
phys.org — “(Phys.org) -- A nanoparticle drug delivery vehicle for small interfering RNA molecules (siRNA), that is already being tested in human clinical trials, now shows promise for the treatment of head and neck cancer. Dong Shin, of Emory University, and Mark E. Davis, of the Nanosystems Biology Cancer Center ...” View full resource at phys.org
Most Recently Shared on April 6, 2012 at 2:07 pm By:
Nanoparticle-delivered RNA interference drug stops head and neck cancer growth http://t.co/Sa7qTaiC
Possible clues found to why HIV vaccine showed modest protection, April 4, 2012 News Release - National Institutes of Health (NIH)
nih.gov — “Insights into how the first vaccine ever reported to modestly prevent HIV infection in people might have worked were published online today in the New England Journal of Medicine. Scientists have found that among adults who received the experimental HIV vaccine during the landmark RV144 clinical trial, those who produced relatively high levels of a specific antibody after vaccination were less likely to get infected with the virus than those who did not. The National Institute of Allergy and Inf” View full resource at nih.gov
Most Recently Shared on April 5, 2012 at 12:38 pm By:
News: Possible clues found to why HIV vaccine showed modest protection http://t.co/xPTgxsxq
Advertisement

